Bormioli Pharma, a specialist in pharmaceutical packaging and medical devices, will be present at CPHI Milan (Fiera Milano, booth 20A2) from 8-10 October.
Ahead of CPHI Japan 2023, Ian Haydock, Citeline, predicts that the continued rise of biopharma innovation in China is the big macro trend in the APAC region that could potentially lead to shifts in outsourcing and manufacturing strategies regionally.
Rebekah Jordan gives a review of the recent CPhI Frankfurt 2022 event: observing noteworthy innovations, key themes across the industry, and the latest developments in pharma aiming to tackle trending issues.
In a keynote session at CPHI North America, Stephanie Gaulding, executive director of regulatory compliance at Pharmatech Associates, calls for innovators to look closely at the frameworks they agree to and work to mitigate future challenges.
A stark warning that ‘innovation is being hindered by regulators’ has been given by the president of EPCOT International, Girish Malhotra, in the first part of CPhI Worldwide’s sixth annual report.
According to CPhI Korea, the Korean pharma market is experiencing significant growth in finished drug products, which is being attributed to an expanding domestic generics market.
A recent report from CPhI Japan has forecast that this year, 2018, will be a transformative year for Japanese pharma as the market is expected to see growth in generics, biosimilars and internationalisation.
Pre-audited figures from the organisers of the largest pharma event CPhI Worldwide have revealed that 44,500 people attended this year’s event in Frankfurt, which also hosted 2,598 exhibitors.
